Michael Lioudis

Cleveland Clinic

Papers

4

Total Citations

85

H-Index

4

About

Dr. Michael Lioudis is a urologic surgeon and researcher whose work centers on advancing minimally invasive treatments for kidney cancer, with a particular focus on optimizing outcomes in robotic partial nephrectomy (RPN). His major contributions lie in refining surgical techniques to preserve renal function without compromising oncological control. In a landmark study with 37 citations, he demonstrated that transperitoneal robot-assisted partial nephrectomy achieves excellent long-term oncological and functional outcomes at a minimum of five years of follow-up. Dr. Lioudis has also pioneered comparative effectiveness research, using propensity-score matching to show that RPN offers superior perioperative and functional results over cryoablation in elderly patients (26 citations) and that cold ischemia during RPN can match the renal protection of the traditional open approach (14 citations). Further, his work on “at-risk” patients (8 citations) established that cold ischemia RPN better preserves kidney function than warm ischemia in this vulnerable population. Through these rigorous, clinically impactful studies, Dr. Lioudis has helped establish robotic partial nephrectomy as a safe, effective standard of care, advancing the field toward more personalized, kidney-sparing surgery.

Research Focus

Key Achievements

4
H-Index
4
Papers
85
Total Citations
21
Avg Citations/Paper
🏆 Most Cited Paper
Transperitoneal Robot-assisted Partial Nephrectomy with Minimum Follow-up of 5 Years: Oncological and Functional Outcomes from a Single Institution
37 citations · 2018
📈 Most Prolific Year: 2018 (2 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Cleveland Clinic

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago